Literature DB >> 28353273

Clinical characteristics of children with hemolytic uremic syndrome in Hangzhou, China.

Shui-Ai Zhao1, Bo-Tao Ning2, Jian-Hua Mao1.   

Abstract

BACKGROUND: Hemolytic uremic syndrome (HUS) is a main cause of acute renal failure in children. This study aimed to analyze the clinical characteristics of HUS.
METHODS: A retrospective analysis was performed in 46 children with sporadic HUS.
RESULTS: Of the 46 HUS patients, 20 (43.5%) were diarrhea-related HUS, and 26 (56.5%) were atypical HUS. Anemia, edema, oliguria, hemoglobinuria and hypertension were the most common manifestations. Thrombocytopenia, hyponatremia, hypocalcemia, hyperkalemia, metabolic acidosis, increased fibrinogen and hypocomplementemia were found in most patients. The age of onset (younger than 2 years or not, P=0.009), the duration of oliguria or anuria (more than one week or not, P=0.005), accompanied with extrarenal complications or not (P=0.005), dialysis and plasma exchange (P=0.04) were associated with the mortality rate.
CONCLUSIONS: The age of onset younger than 2 years, oliguria/anuria more than 1 week, and associated with extrarenal complications were predictive factors of poor prognosis.

Entities:  

Keywords:  hemolytic uremic syndrome; prognosis; therapy

Mesh:

Year:  2017        PMID: 28353273     DOI: 10.1007/s12519-017-0021-x

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  11 in total

1.  Postdiarrheal hemolytic uremic syndrome in United States children: clinical spectrum and predictors of in-hospital death.

Authors:  Rajal K Mody; Weidong Gu; Patricia M Griffin; Timothy F Jones; Josh Rounds; Beletshachew Shiferaw; Melissa Tobin-D'Angelo; Glenda Smith; Nancy Spina; Sharon Hurd; Sarah Lathrop; Amanda Palmer; Effie Boothe; Ruth E Luna-Gierke; Robert M Hoekstra
Journal:  J Pediatr       Date:  2015-02-04       Impact factor: 4.406

2.  Re-evaluating criteria for peritoneal dialysis in "classical" (D+) hemolytic uremic syndrome.

Authors:  R Bhimma; H M Coovadia; M Adhikari; C A Connolly
Journal:  Clin Nephrol       Date:  2001-02       Impact factor: 0.975

3.  Identification of plasma antifibrin/fibrinogen antibodies in a patient with hemolytic uremic syndrome.

Authors:  Gail Rock; Maria Kolajova; Caroline Faught; Deborah Zimmerman
Journal:  Blood Coagul Fibrinolysis       Date:  2006-10       Impact factor: 1.276

4.  Plasma exchange therapy for the treatment of Escherichia coli O-157 associated hemolytic uremic syndrome.

Authors:  Tatsuya Nakatani; Kenji Tsuchida; Rikio Yoshimura; Kazunobu Sugimura; Yoshiaki Takemoto
Journal:  Int J Mol Med       Date:  2002-11       Impact factor: 4.101

5.  Risk factors for poor renal prognosis in children with hemolytic uremic syndrome.

Authors:  Alessandra Gianviti; Alberto E Tozzi; Laura De Petris; Alfredo Caprioli; Lucilla Ravà; Alberto Edefonti; Gianluigi Ardissino; Giovanni Montini; Graziella Zacchello; Alfonso Ferretti; Carmine Pecoraro; Tommaso De Palo; Angela Caringella; Maurizio Gaido; Rosanna Coppo; Francesco Perfumo; Nunzia Miglietti; Ilse Ratsche; Rosa Penza; Giovambattista Capasso; Silvio Maringhini; Salvatore Li Volti; Carmen Setzu; Marco Pennesi; Alberto Bettinelli; Leopoldo Peratoner; Ivana Pela; Elio Salvaggio; Giuliana Lama; Salvatore Maffei; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2003-10-31       Impact factor: 3.714

6.  Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS).

Authors:  Lubka T Roumenina; Roxane Roquigny; Caroline Blanc; Nelly Poulain; Stéphanie Ngo; Marie-Agnès Dragon-Durey; Véronique Frémeaux-Bacchi
Journal:  Methods Mol Biol       Date:  2014

7.  The role of plasma exchange in the treatment of severe forms of hemolytic-uremic syndrome in childhood.

Authors:  J Slavicek; Z Puretić; M Novak; V Sarnavka; V Benjak; S Glavas-Boras; S Thune
Journal:  Artif Organs       Date:  1995-06       Impact factor: 3.094

8.  Long-term follow-up of Argentinean patients with hemolytic uremic syndrome who had not undergone dialysis.

Authors:  Carlos J Cobeñas; Laura F Alconcher; Ana P Spizzirri; Ricardo C Rahman
Journal:  Pediatr Nephrol       Date:  2007-06-13       Impact factor: 3.714

9.  Incidence and index of severity of hemolytic uremic syndrome in a 26 year period in Fukushima Prefecture, Japan.

Authors:  Yukihiko Kawasaki; Kazuhide Suyama; Ryo Maeda; Eichi Yugeta; Kei Takano; Shigeo Suzuki; Hiroko Sakuma; Kenji Nemoto; Tomoko Sato; Katsutoshi Nagasawa; Mitsuaki Hosoya
Journal:  Pediatr Int       Date:  2014-02       Impact factor: 1.524

10.  Hemolytic uremic syndrome risk and Escherichia coli O157:H7.

Authors:  Boldtsetseg Tserenpuntsag; Hwa-Gan Chang; Perry F Smith; Dale L Morse
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.